CA Patent

CA3263646A1 — [177lu] lutetium-psma l&t composition, kit, method of making, and method of using thereof

Assigned to Curium US LLC · Expires 2024-07-18 · 2y expired

What this patent protects

Patent listed against Posluma.

Drugs covered by this patent

Patent Metadata

Patent number
CA3263646A1
Jurisdiction
CA
Classification
—
Expires
2024-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Curium US LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.